Revenue Dependence on a Specific Medical Corporation
First written in FY2017. 4 of 5 entries say "Mitigated", first in FY2019. Latest entry: FY2025.
1 other company's latest entry also says "Mitigated".
- FY2025MitigatedAnnual report
「Of net sales of ¥810.291 million for the fiscal year ended September 2025, sales to the medical corporation 医療法人社団滉志会 amounted to ¥446.859 million, or 55.1% of net sales, indicating that the Group is currently highly dependent on this medical corporation.」
Dependence on sales to 医療法人社団滉志会 declined from 59.8% in the previous fiscal year to 55.1%, but the disclosure states that dependence remains high. - FY2023MitigatedAnnual report
「Of net sales of ¥661.543 million for the fiscal year ended September 2023, sales to the medical corporation 医療法人社団滉志会 amounted to ¥398.845 million, or 60.3% of net sales, indicating that the Group is currently highly dependent on this medical corporation.」
Dependence on sales to 医療法人社団滉志会 declined slightly from 60.5% in the previous fiscal year to 60.3%, but the disclosure states that dependence remains high. - FY2022MitigatedAnnual report
「Of net sales of ¥633.672 million for the fiscal year ended September 2022, sales to Medical Corporation Koshikai were ¥383.259 million, representing 60.5% of net sales, indicating that the Company currently has a high level of dependence on that medical corporation.」
Dependence on sales to the specific medical corporation declined from 93.6% to 69.4% and then to 60.5%. The disclosure continues to state that dependence remains high. - FY2019MitigatedAnnual report
「Of net sales of ¥1,059.021 million for the fiscal year ended September 2019, sales to the medical corporation 医療法人社団滉志会 amounted to ¥735.206 million, or 69.4% of net sales, indicating that the Group is currently highly dependent on this medical corporation.」
Dependence on sales to 医療法人社団滉志会 declined from 93.6% in the previous disclosure to 69.4%, but remains high. - FY2017First statedAnnual report
「Of consolidated revenue of ¥1,704,004 thousand in the fiscal year ended September 2017, total revenue from the four medical institutions operated by Medical Corporation Kou志会 was ¥1,594,107 thousand, representing 93.6% of consolidated revenue. The Company therefore remains highly dependent on this medical corporation.」
The Company disclosed customer concentration risk, with 93.6% of consolidated revenue dependent on four medical institutions operated by one medical corporation.